Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
39
STIM Quote, Financials, Valuation and Earnings
Last price:
$3.83
Seasonality move
:
-4%
Day range:
$3.53 - $3.83
52-week range:
$0.52 - $5.92
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.60x
P/B ratio:
6.71x
Volume:
1.6M
Avg. volume:
875.7K
1-year change:
80%
Market cap:
$238M
Revenue:
$74.9M
EPS (TTM):
-$1.31
Earnings Data
Next earnings date for STIM
Aug 12
2025
Most recent earnings per share
-$0.21
Missed by $0.09
(May 6/2025)
Consensus Estimate
-$0.12
(May 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
STIM Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $38.2M | -- | -- | -$0.07 | -- |
| 08/12/2025 | Q2 | $36.9M | -- | -- | -$0.08 | -- |
| 05/06/2025 | Q1 | $29.1M | $32M | -$0.21 | -$0.12 | -$0.09 |
| 03/04/2025 | Q4 | $19M | $22.5M | -$0.33 | -$0.24 | -$0.09 |
| 11/12/2024 | Q3 | $19.1M | $18.5M | -$0.44 | -$0.23 | -$0.21 |
| 08/12/2024 | Q2 | $18.7M | $16.5M | -$0.33 | -$0.27 | -$0.06 |
| 05/07/2024 | Q1 | $17.1M | $17.4M | -$0.27 | -$0.31 | $0.04 |
| 03/05/2024 | Q4 | $20M | $20.3M | -$0.19 | -$0.26 | $0.07 |
| 11/07/2023 | Q3 | -- | -- | -$0.33 | -$0.29 | -$0.05 |
| 08/08/2023 | Q2 | -- | -- | -$0.17 | -$0.35 | $0.18 |
| 05/09/2023 | Q1 | -- | -- | -$0.38 | -$0.39 | $0.01 |
| 03/07/2023 | Q4 | -- | -- | -$0.30 | -$0.38 | $0.08 |
| 11/08/2022 | Q3 | -- | -- | -$0.28 | -$0.43 | $0.15 |
| 08/02/2022 | Q2 | -- | -- | -$0.39 | -$0.41 | $0.02 |
| 05/12/2022 | Q1 | -- | -- | -$0.41 | -$0.40 | -$0.01 |
| 03/08/2022 | Q4 | -- | -- | -$0.29 | -$0.32 | $0.03 |
| 11/09/2021 | Q3 | -- | -- | -$0.31 | -$0.30 | -$0.01 |
| 08/03/2021 | Q2 | -- | -- | -$0.29 | -$0.24 | -$0.05 |
| 05/04/2021 | Q1 | -- | -- | -$0.31 | -$0.31 | -$0.00 |
| 03/02/2021 | Q4 | -- | -- | -$0.19 | -$0.26 | $0.07 |
| 11/02/2020 | Q3 | -- | -- | -$0.18 | -$0.28 | $0.10 |
| 08/04/2020 | Q2 | -- | -- | -$0.41 | -$0.50 | $0.09 |
| 05/05/2020 | Q1 | -- | -- | -$0.68 | -$0.46 | -$0.22 |
| 03/03/2020 | Q4 | -- | -- | -$0.41 | -$0.45 | $0.04 |
| 11/05/2019 | Q3 | -- | -- | -$0.37 | -$0.43 | $0.06 |
| 08/06/2019 | Q2 | -- | -- | -$0.39 | -$0.41 | $0.02 |
| 05/07/2019 | Q1 | -- | -- | -$0.42 | -$0.40 | -$0.02 |
| 03/05/2019 | Q4 | -- | -- | -$0.35 | -$0.36 | $0.01 |
| 11/06/2018 | Q3 | -- | -- | -$0.29 | -$0.40 | $0.11 |
| 08/14/2018 | Q2 | -- | -- | -$0.67 | -$0.88 | $0.21 |
Neuronetics Earnings Questions
-
How Much did Neuronetics Generate in Revenue Last Quarter?
Neuronetics reported $32M worth of top line sales in its most recent quarter.
-
Did Neuronetics Beat Earnings Last Quarter?
Neuronetics announced earnings per share of -$0.21 which represents a miss of analyst forecast a -$0.12 per share.
-
Is Neuronetics Profitable?
Neuronetics reported $15.7M that represents $0.26 per share over the last quarter.
-
What is the Analyst Consensus for Neuronetics EPS Next Year?
Neuronetics's earnings are forecast to decrease from -$1.38 per share to -$1.27 per share next year representing a decrease of -74.28%.
-
When is Neuronetics's Earnings Date?
Neuronetics's next earnings date is August 12, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
